Ontario is now halting first doses of AstraZeneca’s COVID-19 vaccine amid an increased risk in rare blood clot linked to the shot. The decisions also comes after Alberta made a similar move, saying it’s primarily because of the vaccine’s dwindling supply. Eric Sorensen reports on the growing uncertainty and the evolving science around the vaccine.
Global National
Ontario joins Alberta in halting first doses of AstraZeneca vaccine
More Videos
-
ICE taps Ontario firm for 20 armoured vehicles
-
Ottawa, B.C. unveil anti-extortion measures
-
Canada, Ontario spending $3B on small modular reactors
-
Unplugged: GM ending electric van production at Ontario plant
-
How will Stellantis’ U.S. move impact Canada’s auto sector?
-
Hard foul: Why prized Canadian basketball artifacts could move to U.S.
You are viewing an Accelerated Mobile Webpage.
View Original Article